Physio-Control, Inc.
Physio-Control, Inc., a leading name in the medical device industry, is headquartered in the United States and operates extensively across North America and Europe. Founded in 1955, the company has established itself as a pioneer in emergency medical response technology, particularly in the development of automated external defibrillators (AEDs) and advanced cardiac monitoring systems. Physio-Control's core products, including the LIFEPAK series, are renowned for their innovative design and user-friendly features, making them essential tools for first responders and healthcare professionals. The company has achieved significant milestones, such as being a trusted partner in numerous high-profile emergency medical services. With a strong market position, Physio-Control continues to lead the way in enhancing patient outcomes through cutting-edge technology and comprehensive training solutions.
DitchCarbon Score
How does Physio-Control, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Physio-Control, Inc.'s score of 39 is higher than 65% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Physio-Control, Inc., headquartered in the US, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of Stryker Corporation, which influences its climate commitments and initiatives. While there are no direct reduction targets or achievements reported for Physio-Control, it inherits sustainability initiatives from Stryker Corporation. This includes commitments to the Science Based Targets initiative (SBTi) and participation in the Carbon Disclosure Project (CDP), both of which aim to drive significant reductions in greenhouse gas emissions across their operations. As part of its corporate family, Physio-Control aligns with Stryker's broader climate strategies, although specific targets and metrics for emissions reductions have not been disclosed at this level. The absence of detailed emissions data suggests that the company is still in the process of establishing its own climate commitments or reporting frameworks. Overall, while specific emissions figures are not available, Physio-Control is positioned within a corporate structure that prioritises sustainability and climate action through its parent company, Stryker Corporation.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Scope 1 | - | - | - | - | 00,000,000 |
| Scope 2 | 146,705,000 | - | 000,000,000 | 000,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Physio-Control, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
